A Simulation Model for Colorectal Cancer Screening: Potential of Stool Tests with Various Performance Characteristics Compared with Screening Colonoscopy | Citedby Results | Cancer Epidemiology, Biomarkers & Prevention | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

A Simulation Model for Colorectal Cancer Screening: Potential of Stool Tests with Various Performance Characteristics Compared with Screening Colonoscopy

Cancer Epidemiol Biomarkers Prev (2005) 14 (2): 422–428.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

A simulation model of colorectal cancer surveillance and recurrence

Johnie Rose
Knut Magne Augestad
Chung Yin Kong
Neal J Meropol
Michael W Kattan
Qingqing Hong
Xuebei An
Gregory S Cooper

BMC Medical Informatics and Decision Making (2014) 14 (1)

The Colorectal Cancer Screening Process in Community Settings: A Conceptual Model for the Population-Based Research Optimizing Screening through Personalized Regimens Consortium

Jasmin A. Tiro
Aruna Kamineni
Theodore R. Levin
Yingye Zheng
Joanne S. Schottinger
Carolyn M. Rutter
Douglas A. Corley
Celette S. Skinner
Jessica Chubak
Chyke A. Doubeni
Ethan A. Halm
Samir Gupta
Karen J. Wernli
Carrie Klabunde

Cancer Epidemiology, Biomarkers & Prevention (2014) 23 (7): 1147.

Screening

Claudia Spix
Maria Blettner

Deutsches Ärzteblatt international (2012)

A combination of faecal tests for the detection of colon cancer

Fabrizio Parente
Barbara Marino
Antonina Ilardo
Pierluigi Fracasso
Angelo Zullo
Casare Hassan
Roberto Moretti
Marco Cremaschini
Antonio Ardizzoia
Ilaria Saracino
Federico Perna
Dino Vaira

European Journal of Gastroenterology & Hepatology (2012) 24 (10): 1145.

Upregulation of Fecal Cytokeratin 19 Is Associated with Prognosis in Older Colorectal Cancer Patients

Ruey-Neng Yang
Shung-Haur Yang
Chun-Chao Chang
Chih-Cheng Chien
Shiann Pan
Chi-Jung Huang

Genetic Testing and Molecular Biomarkers (2010) 14 (5): 703.

What is a Reasonable Screening Test for Colorectal Cancer

Young Jin Kim

Journal of the Korean Society of Coloproctology (2010) 26 (6): 375.

Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines

Natasha K. Stout
Amy B. Knudsen
Chung Yin Kong
Pamela M. McMahon
G. Scott Gazelle

PharmacoEconomics (2009) 27 (7): 533.

Faecal ribosomal protein L19 is a genetic prognostic factor for survival in colorectal cancer

C.-J Huang
C.-C. Chien
S.-H. Yang
C.-C. Chang
H.-L. Sun
Y.-C. Cheng
C.-C. Liu
S.-C. Lin
C.-M. Lin

Journal of Cellular and Molecular Medicine (2008) 12 (5b): 1936.

Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients

U Haug
D Rothenbacher
M N Wente
C M Seiler
C Stegmaier
H Brenner

British Journal of Cancer (2007) 96 (9): 1329.

Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC)

Chih-Cheng Chien
Shu-Hung Chen
Chen-Chiung Liu
Chia-Long Lee
Ruey-Neng Yang
Shung-Haur Yang
Chi-Jung Huang

Translational Research (2007) 149 (2): 96.

Reply: New faecal tests for colorectal cancer screening: is tumour pyruvate kinase M2 one of the options?

U Haug
H Brenner

British Journal of Cancer (2007) 97 (11): 1597.

A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test

Z. LEVI
R. HAZAZI
P. ROZEN
A. VILKIN
A. WAKED
Y. NIV

Alimentary Pharmacology and Therapeutics (2006) 23 (9): 1359.

Analytic methods for colorectal cancer

Carol J. Etzel
Sumesh Kachroo

Current Colorectal Cancer Reports (2006) 2 (4): 206.